Clinical Trials Directory

Trials / Unknown

UnknownNCT04485897

Self-monitoring of the Intraocular Pressure Versus Hospital-based Diurnal Monitoring

Can Self-monitoring of the Intraocular Pressure With the Icare HOME Make Hospital-based Diurnal Monitoring Redundant?

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
25 (estimated)
Sponsor
Luzerner Kantonsspital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Glaucoma remains the leading cause of irreversible blindness worldwide. Glaucoma represents a group of diseases that lead to optic nerve damage and corresponding deterioration of the visual field. Elevated intraocular pressure remains the most important risk factor. Interestingly, glaucomatous damage sometimes occurs despite seemingly normal intraocular pressure. Recent studies suggest pressure peaks, which are missed under the current practice of spot intraocular measurements during office hours. In order to detect pressure peaks diurnal measurements are mandatory. Costly in-hospital diurnal measurements are the current standard. The primary study objective is to verify that self-tonometry at home can provide valuable information when looking for pressure peaks in patients with glaucoma.

Conditions

Interventions

TypeNameDescription
DEVICEicare HOME device (Icare Oy, Vanda, Finland)icare HOME device versus hospital based measurements

Timeline

Start date
2020-11-26
Primary completion
2024-08-01
Completion
2024-08-01
First posted
2020-07-24
Last updated
2024-03-06

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT04485897. Inclusion in this directory is not an endorsement.